← All diseases Cancer

Liver cancer

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchOnly the most robust evidence (78)Meta-analysis (34)Treatment guideline (5)Systematic review (18)Randomized trial (14)Phase 3 study (7)Clinical trial (608)Review article (448)Early study (phase 1 or 2) (26)Laboratory or animal research (164)Case report (110)Commentary or editorial (69)Retracted publication (8)Concerns have been raised (1) Studies currently recruiting participants only (41)

Filter

Publications and studies (3377)

• Detailed racial/ethnic disparities in hepatocellular carcinoma risk with an electronic health record-based cohort. (2026/08/04) ♡
• Metabolic Dysfunction-Associated Steatotic Liver Disease Reprograms the Hepatic Metastatic Niche. (2026/08/04) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Diffusion-Weighted Imaging-Based Virtual MR Elastography of the Liver: Beyond Mechanical Waves. (2026/08/04) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Beyond Diagnosis: Magnetic Resonance Imaging-Based Imaging Biomarkers for Tumor Biology, Prognosis, and Clinical Decision-Making in Hepatocellular Carcinoma. (2026/08/04) ♡
• Hepatocyte MLKL drives obesity-driven hepatocellular carcinoma progression via mitochondrial dysfunction independent of necroptosis in MASLD. (2026/08/04) ♡
• Computational screening of natural compounds reveals glycyrrhisoflavone as a potential Hepatitis B X-interacting protein inhibitor. (2026/08/03) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A 19-Year-Old Woman With Pulmonary and Vertebral Lesions Suggestive of Metastatic Hepatocellular Carcinoma. (2026/08/01) ♡
• TALDO1 promotes lipid metabolic reprogramming and immunosuppressive microenvironment remodelling in hepatocellular carcinoma. (2026/08/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The "A-B-C" Classification Reveals Outcome Trajectories in Patients With Hepatocellular Carcinoma Under Atezolizumab/Bevacizumab. (2026/08/01) ♡
• Jianpi Huayu decoction suppresses hepatocellular carcinoma invasion and metastasis by inhibiting SIRT5-regulated Nrf2 activation and mitochondrial metabolic reprogramming. (2026/08/01) ♡
• Genetically predicted gut bacteria, circulating bacteria-associated metabolites and liver cancer: A Mendelian randomisation study. (2026/08/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Artificial Intelligence in Surveillance of Hepatocellular Carcinoma: Hype or Reality? (2026/08/01) ♡
• Catecholamines Activate a Tumour Progression Program in Differentiated Tumour Hepatocytes. (2026/08/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Gut Microbiota, Immunity, and Metabolism in the Progression From Chronic Liver Disease to Hepatocellular Carcinoma. (2026/08/01) ♡
• Glucosamine Promotes Autophagy and Attenuates Hepatic Steatosis Via O-GlcNAcylation-Mediated Mechanisms. (2026/08/01) ♡
• Artificial Intelligence/Machine Learning-Driven cfDNA Methylation Blood Test for Early Cancer Detection in Military Personnel With Environmental Toxin Exposure. (2026/08/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Hepatitis B virus-specific T cell receptor therapy for advanced hepatocellular carcinoma: lessons from Wu et al. (2026/08/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. From local control to immune synergy: the evolving role of stereotactic body radiotherapy in the immunotherapy era of hepatocellular carcinoma. (2026/08/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Dual TIGIT and PD-1 blockade in immunotherapy-refractory hepatocellular carcinoma: a signal beyond resistance? (2026/08/01) ♡
• A trifluoromethyl quinazoline inhibits hepatocellular carcinoma proliferation through HDAC1 binding and multi-target mechanisms. (2026/07/31) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Design, robust synthesis, and anti-liver cancer activity of 2-hydrazono-5-acetyl-[1,3,4]thiadiazole and N'-ethylideneethanethiohydrazide derivatives: In vitro, gene expression, DNA damage, and DNA fragmentation. (2026/07/31) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Alcoholic cirrhosis with Wernicke encephalopathy: Clinical case report. (2026/07/31) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Alcohol and tobacco in cancer: A unified framework of interaction across carcinogenic pathways and cancer types. (2026/07/31) ♡
• Clinical Practice Guidelines for Adult MASLD in Bosnia and Herzegovina: National Recommendations for Diagnosis, Risk Stratification, and Treatment. (2026/07/30) ♡
• Exosome-delivered miR-769-3p promotes malignant progression of hepatocellular carcinoma via ALKBH5-dependent m(6)A modification. (2026/07/29) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Transforming the treatment landscape for unresectable hepatocellular carcinoma: A perspective on transarterial chemoembolization-anchored triple-combination therapy. (2026/07/29) ♡
• Jiawei Taohe Chengqi decoction alleviates angiogenesis associated with LECT2/CD209-mediated macrophage reprogramming in hepatic fibrosis. (2026/07/29) ♡
• Prognostic significance of prior alcohol use disorder in patients with presumed metabolic dysfunction-associated steatotic liver disease: A large multi-center cohort study. (2026/07/29) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. FN1 Knockout Inhibits Tumorigenesis but Promotes Lung Metastasis in Hepatocellular Carcinoma. (2026/07/28) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Advances in Lipid Metabolism Reprogramming in Hepatocellular Carcinoma. (2026/07/28) ♡
• Imipramine Reverses Sorafenib Resistance in Hepatocellular Carcinoma by Targeting the BLOC1S5/FOXO1 Signaling Axis. (2026/07/28) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The immunoecology of occult hepatitis B virus infection: genetic remodeling and the immune-mediated microcosm. (2026/07/27) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Commentary: Case Report: Multimodal management of duodenal metastasis from hepatocellular carcinoma complicated by intractable hemorrhage. (2026/07/27) ♡
• A streamlined predictive model for predicting the risk of recurrence after liver transplantation for hepatocellular carcinoma was constructed based on preoperative (18)F-FDG PET/CT metabolic parameters and clinicopathological features. (2026/07/27) ♡
• Prenylated flavonoids from Sophora flavescens (Kushen) inhibit hepatocellular carcinoma growth by suppressing the Akt/MDM2/p53 pathway to activate mitochondrial apoptosis. (2026/07/25) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Non-pharmacological treatment of MASLD. (2026/07/25) ♡
• Bioinformatic characterization of SLC25A39 across cancers with validation in hepatocellular carcinoma. (2026/07/25) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Exercise and cold exposure as dual physiological stressors in MASLD: AMPK-mediated metabolic adaptation and interorgan crosstalk. (2026/07/24) ♡
• Liver resection is associated with better survival than TACE for hepatocellular carcinoma modestly beyond Milan criteria: a multicenter propensity-matched analysis. (2026/07/24) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. MEOX2: a homeobox transcription factor with multifaceted biological functions and broad disease associations. (2026/07/23) ♡
• Ultrasound-engineered chitosan nanocarriers improve the anticancer activity of dandelion phytochemicals in hepatocellular carcinoma cells. (2026/07/23) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Artificial intelligence driven exposome and multi omics integration for biomarker discovery in liver cancer: a literature review. (2026/07/23) ♡
• Prediction of early treatment response to drug-eluting beads chemoembolization for hepatocellular carcinoma using machine learning. (2026/07/23) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Beyond cardiovascular protection: a conceptual and translational review of the hepato-specific mechanisms of statins in metabolic dysfunction-associated steatotic liver disease (MASLD). (2026/07/23) ♡
• Synergistic nanoparticle dyad improving tumor immunogenicity and reshaping tolerogenic dendritic cells in hepatocellular carcinoma. (2026/07/23) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Safe hepatectomy in patients with constitutional indocyanine green excretory defect: two case reports highlighting multimodal functional assessment. (2026/07/22) ♡
• Impact of a Short-Term High-Fat Diet on Lifespan and Tumorigenesis After Early-Life Exposure to Radiation. (2026/07/22) ♡
• Mapping cancer dynamics from normal tissue to malignancy using N- and T-gene expression markers. (2026/07/22) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. From anatomical to biological resectability: navigating adaptive resistance in hepatocellular carcinoma conversion. (2026/07/22) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Ferroptosis in liver diseases: molecular mechanisms, biomarker potential, and clinical translation. (2026/07/22) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.